TEI 6122
Alternative Names: 7-Thiaprostaglandin E1; TFC 612Latest Information Update: 22 Feb 2001
At a glance
- Originator Teijin Pharma
- Class Anticoagulants; Prostaglandins; Vasodilators
- Mechanism of Action Prostaglandin E1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis
Most Recent Events
- 22 Feb 2001 Discontinued-II for Thrombosis (PO)
- 09 Apr 1997 No-Development-Reported for Coronary thrombosis (PO)
- 18 Jan 1995 Phase-I clinical trials for Coronary thrombosis (PO)